Borrelia-WB-IgM

Serum
check icon Reference range:

Understanding the Borrelia WB IgM Biomarker and Its Role in Lyme Disease Diagnosis

The Borrelia Western Blot (WB) IgM test is a significant tool in the diagnosis of Lyme disease, an infection caused by the Borrelia burgdorferi bacteria, transmitted primarily through tick bites. The IgM test specifically detects early immune responses to the bacteria and is a valuable marker during the initial weeks following exposure. The presence of IgM antibodies, which are the first line of defense, provides insight into whether an infection is recent, as IgM antibodies typically appear within one to two weeks of exposure and may decline after a few months. Given that Lyme disease can present with a range of symptoms that mimic other illnesses, accurately interpreting IgM and other biomarkers is essential for both timely treatment and effective management of the disease.

What is Borrelia WB IgM?

IgM (Immunoglobulin M) is one of the earliest antibodies produced by the immune system when it encounters a foreign pathogen like Borrelia burgdorferi. In Lyme disease, IgM antibodies specifically target unique proteins on the Borrelia bacteria’s cell surface. The Western Blot test is a method that separates these proteins by their size, allowing for the identification of specific antibodies that bind to Borrelia proteins, thus helping to confirm infection. For Borrelia WB IgM, a positive result requires reactivity against at least two out of three specific protein bands: 24 kDa (OspC), 39 kDa (BmpA), and 41 kDa (flagellin). If these bands are present, it generally suggests a recent infection with Borrelia, as the IgM response occurs early and may subside as the infection progresses.

Importance of IgM in the Early Stages of Lyme Disease

The IgM test is especially significant within the first 4-6 weeks of infection, as the immune system initially mounts an IgM response before producing IgG antibodies, which provide longer-lasting immunity. A positive IgM result alongside Lyme-specific symptoms (such as fever, fatigue, joint pain, and in some cases, the characteristic bullseye rash) supports a diagnosis of early Lyme disease and indicates that the infection is likely recent. Prompt diagnosis based on IgM positivity can be crucial, as early treatment with antibiotics can prevent the progression of Lyme disease to more advanced, chronic stages.

It is important to note that IgM antibodies may also remain detectable for a period after infection, even as symptoms subside or resolve, sometimes resulting in lingering IgM reactivity for months. Therefore, a positive IgM test alone does not always indicate an active infection; it must be interpreted within the clinical context, especially if symptoms have resolved or if the patient has been treated previously.

The Relationship Between IgM, P100, and IgG in Lyme Disease

In the broader context of Lyme disease diagnostics, the IgM biomarker often works alongside other markers such as P100 and IgG to create a more comprehensive picture of the infection status. While IgM is associated with the early response, IgG represents a more established immune response that appears later and provides a longer-term indication of exposure. IgG antibodies often develop after 4-6 weeks of infection and can remain detectable for years, even after the infection has resolved. In the Western Blot IgG test, a positive result requires reactivity to at least 5 out of 10 specified bands, reflecting a more mature immune response.

The P100 biomarker, in particular, has a unique role in this diagnostic landscape. P100 is a protein antigen that appears mainly in later stages of the infection or in cases where the immune system has been engaged for an extended period. It is often more relevant in chronic or late-stage Lyme disease, where a patient’s immune system continues to show signs of response to Borrelia antigens long after initial exposure. A positive P100 may indicate that a patient had a prolonged or persistent infection, especially if combined with positive IgG markers.

However, P100 does not typically appear in the early stages of infection and is not included in the standard criteria for diagnosing acute Lyme disease. Thus, in an initial diagnostic panel, IgM and IgG are the primary markers used to identify early and progressing infections. If IgM is positive and P100 is negative, it may suggest a recent infection that has not yet stimulated an immune response to proteins like P100, which emerge later. Conversely, if both IgG and P100 are positive but IgM is negative, it could indicate a past or chronic infection rather than an active, acute infection.

Clinical Interpretation of Borrelia WB IgM in Relation to Other Markers

Interpreting Borrelia WB IgM in conjunction with IgG and P100 can be challenging, as the immune response to Borrelia burgdorferi is known to vary between individuals. Additionally, Lyme disease’s unique ability to evade immune detection can result in fluctuating antibody levels over time, complicating interpretation. Therefore, the timing of symptom onset, recent tick exposure, and progression of symptoms are key factors in determining the diagnostic significance of each marker.

In cases where only IgM is positive, but IgG and P100 are negative, the finding suggests a potential early infection that warrants further clinical follow-up and possibly retesting after a few weeks. If symptoms persist or worsen, IgG and P100 may eventually become positive, reflecting a transition to a later stage of immune response.

When IgG is positive and IgM is negative, it generally indicates an older infection or residual antibodies from a past exposure that the immune system has recognized and responded to over time. If both IgG and P100 are positive, it could suggest that the infection has been present for a longer period or that the body is still actively producing antibodies in response to persistent symptoms. A positive P100 in this case is often associated with a chronic immune response, while a negative IgM suggests that the infection is not in its earliest phase.

Limitations and Challenges of IgM Testing

Despite its utility, the Borrelia WB IgM test has limitations. False positives can occur, especially in individuals with autoimmune diseases or those who have experienced other infections that elicit similar antibody responses. Moreover, some patients may test positive for IgM without developing a full-blown Lyme infection or may have a transient IgM response that doesn’t progress to IgG positivity. Consequently, the CDC recommends caution in interpreting IgM results after the first month of symptoms, as lingering IgM without IgG or P100 reactivity might not indicate active infection.

Additionally, some patients with Lyme disease may not produce detectable IgM antibodies at all, particularly if they have a weakened immune response or if testing occurs too late in the infection cycle. Therefore, negative IgM results do not conclusively rule out Lyme disease, particularly in patients with symptoms consistent with the infection. In these cases, clinicians may consider retesting after a few weeks, or using additional testing methods, such as PCR, which detects Borrelia DNA rather than relying solely on antibody responses.

Conclusion

The Borrelia WB IgM biomarker plays a crucial role in identifying early Lyme disease, signaling the body’s initial immune response to Borrelia burgdorferi. When used in combination with IgG and P100, IgM provides valuable insights into the timing and progression of the infection. While IgM is most relevant in the early phase, IgG and P100 are associated with a later or chronic immune response. A comprehensive assessment of all three markers, along with clinical context, allows for a more nuanced understanding of a patient’s Lyme disease status. This approach helps guide treatment decisions and ensures that both recent and past infections are accurately evaluated, enabling timely intervention and improving patient outcomes.

All Your Lab Results.
One Simple Dashboard.

Laboratories

Bring All Your Lab Results Together — In One Place

We accept reports from any lab, so you can easily collect and organize all your health information in one secure spot.

lab corp logo
genova diagnostics logo
quest diagnostics logo
dutch test logo
doctors data logo
vibrant america logo
diagnostic solutions logo
zrt laboratory logo
the great plains laboratory logo
cyrex laboratories logo
spectracell logo

Pricing Table

decoration

Personal plans

$15/ month

Complete Plan

Access your lab reports, explanations, and tracking tools.

  • Import lab results from any provider
  • Track all results with visual tools
  • Customize your reference ranges
  • Export your full lab history anytime
  • Share results securely with anyone
  • Begin with first report entered
  • Cancel or upgrade anytime

$250/ once

Unlimited Account

Pay once, access everything—no monthly fees, no limits.

  • Import lab results from any provider
  • Track all results with visual tools
  • Customize your reference ranges
  • Export your full lab history anytime
  • Share results securely with anyone
  • Receive 10 reports entered for you
  • Skip the $15/month subscription — no recurring payments ever

$45/ month

Pro Monthly

Designed for professionals managing their clients' lab reports

  • Import lab results from any provider
  • Track lab results for multiple clients
  • Customize reference ranges per client
  • Export lab histories and reports
  • Begin with first report entered by us
  • Cancel or upgrade anytime

About membership

What's included in a Healthmatters membership

microscope icon Import Lab Results from Any Source

person icon See Your Health Timeline

book icon Understand What Your Results Mean

textbook icon

textbook icon Visualize Your Results

folder icon

folder icon

card icon Securely Share With Anyone You Trust

Let Your Lab Results Tell the Full Story

What Healthmatters Members Are Saying

5 stars rating

I have been using Healthmatters.io since 2021. I travel all over the world and use different doctors and health facilities. This site has allowed me to consolidate all my various test results over 14 years in one place. And every doctor that I show this to has been impressed. Because with  any health professional I talk to, I can pull up historical results in seconds. It is invaluable. Even going back to the same doctor, they usually do not have the historical results from their facility in a graph format. That has been very helpful.

Anthony

Unlimited Plan Member since 2021

5 stars rating

What fantastic service and great, easy-to-follow layouts! I love your website; it makes it so helpful to see patterns in my health data. It's truly a pleasure to use. I only wish the NHS was as organized and quick as Healthmatters.io. You've set a new standard for health tracking!

Karin

Advanced Plan Member since 2020

5 stars rating

As a PRO member and medical practitioner, Healthmatters.io has been an invaluable tool for tracking my clients' data. The layout is intuitive, making it easy to monitor trends and spot patterns over time. The ability to customize reports and charts helps me present information clearly to my clients, improving communication and outcomes. It's streamlined my workflow, saving me time and providing insights at a glance. Highly recommended for any practitioner looking for a comprehensive and user-friendly solution to track patient labs!

Paul

Healthmatters Pro Member since 2024

Use promo code to save 10% off any plan.

Frequently asked questions

Healthmatters is a personal health dashboard that helps you organize and understand your lab results. It collects and displays your medical test data from any lab in one secure, easy-to-use platform.

  • Individuals who want to track and understand their health over time.
  • Health professionals, such as doctors, nutritionists, and wellness coaches, need to manage and interpret lab data for their clients.

With a Healthmatters account, you can:

  • Upload lab reports from any lab
  • View your data in interactive graphs, tables, and timelines
  • Track trends and monitor changes over time
  • Customize your reference ranges
  • Export and share your full lab history
  • Access your results anytime, from any device

Professionals can also analyze client data more efficiently and save time managing lab reports.

Healthmatters.io personal account provides in-depth research on 4000+ biomarkers, including information and suggestions for test panels such as, but not limited to:

  • The GI Effects® Comprehensive Stool Profile,
  • GI-MAP,
  • The NutrEval FMV®,
  • The ION Profile,
  • Amino Acids Profile,
  • Dried Urine Test for Comprehensive Hormones (DUTCH),
  • Organic Acids Test,
  • Organix Comprehensive Profile,
  • Toxic Metals,
  • Complete Blood Count (CBC),
  • Metabolic panel,
  • Thyroid panel,
  • Lipid Panel,
  • Urinalysis,
  • And many, many more.

You can combine all test reports inside your Healthmatters account and keep them in one place. It gives you an excellent overview of all your health data. Once you retest, you can add new results and compare them.

If you are still determining whether Healthmatters support your lab results, the rule is that if you can test it, you can upload it to Healthmatters.

shield icon

We implement proven measures to keep your data safe.

At HealthMatters, we're committed to maintaining the security and confidentiality of your personal information. We've put industry-leading security standards in place to help protect against the loss, misuse, or alteration of the information under our control. We use procedural, physical, and electronic security methods designed to prevent unauthorized people from getting access to this information. Our internal code of conduct adds additional privacy protection. All data is backed up multiple times a day and encrypted using SSL certificates. See our Privacy Policy for more details.

gdpr compliance image hipaa compliance image